cytostatic therapy and radiation can aggravate anemia, and platinum-based chemotherapy regimens might diminish endogenous erythropoietin Dose-intensified treatment regimens or shortened treatment ...

Purpose. The treatment of cancer-induced anemia with erythropoietin-stimulating agents (ESAs) is reviewed. Summary. Before the introduction of ESAs, the only treatment option for cancer-related ...

Intravenous medicines and iron supplements given during hemodialysis can reduce and prevent anemia in people with chronic kidney disease. Medicines: EPO itself can be given as a shot. Shots of ...

It has long been known that when red blood cells break down or anemia occurs due to bleeding, the hormone erythropoietin (EPO ...

Routine administration of recombinant erythropoietin to patients on hemodialysis has greatly facilitated the management of chronic-kidney-disease-induced anemia. However, this glycoprotein hormone ...